Different effects of abciximab and cytochalasin D on clot strength in thrombelastography

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 1, 2004, Pages 147-153

  Lang, Thomas H ^a   Toller, W ^a   Gutl M ^a   Mahla, E ^a   Metzler, H ^a   Rehak, P ^a   Marz W ^a   Halwachs Baumann, G ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Abciximab; Cytochalasin D; Glycoprotein IIb IIIa; Thrombelastography

Indexed keywords

ABCIXIMAB; CYTOCHALASIN D; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ADULT; AGED; AMPLITUDE MODULATION; ANALYZER; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TEST; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFECT; FEMALE; HUMAN; MALE; PLASMA; PRIORITY JOURNAL; REPRODUCIBILITY; SURGICAL PATIENT; THROMBOCYTE; THROMBOCYTE RICH PLASMA; THROMBOELASTOGRAPHY; BLOOD CLOTTING; COMPARATIVE STUDY; CYTOSKELETON; DOSE RESPONSE; DRUG ANTAGONISM; DRUG INTERACTION; IN VITRO STUDY; MIDDLE AGED;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BLOOD COAGULATION; BLOOD PLATELETS; CYTOCHALASIN D; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBELASTOGRAPHY;

EID: 4444289881     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00555.x     Document Type: Article

References (37)

1. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65.
2. Hogan KA, Weiler H, Lord ST. Mouse models in coagulation. Thromb Haemost 2002; 87: 563-74.
3. Ozier Y, Steib A, Ickx B, Nathan N, Derlon A, Guay J, de Moerloose P. Haemostatic disorders during liver transplantation. Eur J Anaesthesiol 2001; 18: 208-18.
4. Raymond PD, Marsh NA. Alterations to haemostasis following cardiopulmonary bypass and the relationship of these changes to neurocognitive morbidity. Blood Coagul Fibrinolysis 2001; 12: 601-18.
5. Spiess BD. Maintenance of homeostasis in coagulation during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1999; 13: 2-5.
6. Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, Birjiniuk V, Ouimet H, Pasche B, Nelson MJ. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82: 107-17.
7. Kralisz U, Mussur M, Jegier B, Pawlicki L, Majewska E, Iwaszkiewicz A, Ligocka A, Kowalski J, Zaslonka J, Cierniewski C. Activation of blood platelets after percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery. J Thromb Thrombolysis 2000; 10: 255-64.
8. Srinivasa V, Gilbertson LI, Bhavani-Shankar K. Thromboelastography: where is it and where is it heading? Int Anesthesiol Clin 2001; 39: 35-49.
9. Vig S, Chitolie A, Bevan DH, Halliday A, Dormandy J. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis 2001; 12: 555-61.
10. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992; 69: 307-13.
11. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12: 327-37.
12. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest 1983; 72 325-38.
13. Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M. Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999; 89: 580-4.
14. Reid TJ, Snider R, Hartman K, Greilich PE, Carr ME, Alving BM. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets. Vox Sang 1998; 75: 270-7.
15. Greilich PE, Alving BM, O'Neill KL, Chang AS, Reid TJ. A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients. Anesth Analg 1997; 84: 31-8.
16. Khurana S, Mattson JC, Westley S, O'Neill WW, Timmis GC, Safian RD. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997; 130: 401-11.
17. Koster A, Kukucka M, Fischer T, Hetzer R, Kuppe H. Evaluation of post-cardiopulmonary bypass coagulation disorders by differential diagnosis with a multichannel modified thromboelastogram: a pilot investigation. J Extra Corpor Technol 2001; 33: 153-8.
18. Calatzis AN, Haas S, Gödje O, Calatzis AL, Hipp R, Walenga JM. Thrombelastographic coagulation monitoring during cardiovascular surgery with the roTEG coagulation analyzer. In: Pifarré R, ed. Management of Bleeding in Cardiovascular Surgery. Philadelphia: Hanley and Belfus, Inc., 2000: 215-26.
19. Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rudiger S, Taubitz W, Fischer J, Muller I, Meier D, Patscheke H, Schomig A. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors. Thromb Haemost 2000; 83: 915-22.
20. Kleiman NS, Raizner AE, Jordan R, Wang AL, Norton D, Mace KF, Joshi A, Coller BS, Weisman HF. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors. J Am Coll Cardiol 1995; 26: 1665-71.
21. Nielsen VG, Geary BT. Thoracic aorta occlusion-reperfusion decreases hemostasis as assessed by thromboelastography in rabbits. Anesth Analg 2000; 91: 517-21.
22. Nielsen VG, Geary BT, Baird MS. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg 2000; 91: 35-9.
23. Olorundare OE, Simmons SR, Albrecht RM. Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets: a correlative light and electron microscopic investigation. Blood 1992; 79: 99-109.
24. Boldt J, Haisch G, Suttner S, Kumle B, Schellhase F. Are lactated Ringer's solution and normal saline solution equal with regard to coagulation? Anesth Analg 2002; 94: 378-84.
25. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayr M, Calatzis A, Schobersberger W. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system. An in vitro study using Thrombelastograph® Coagulation Analysis (ROTEG®). Anesth Analg 2002; 94: 1280-7.
26. Chandler WL. The thromboelastography and the thromboelastograph technique. Semin Thromb Hemost 1995; 21 (Suppl. 4): 1-6.
27. Hartert H, Schaeder JA. The physical and biological constants of thrombelastography. Biorheology 1962; 1: 31-9.
28. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-43.
29. Bennett IS, Zigmond S, Vilaire G, Cunningham ME, Bednar B. The platelet cytoskeleton regulates the affinity of the integrin alpha(IIb)beta(3) for fibrinogen. J Biol Chem 1999; 274: 25301-7.
30. Fox JE, Shattil SJ, Kinlough-Rathbone RL, Richardson M, Packham MA, Sanan DA. The platelet cytoskeleton stabilizes the interaction between alphaIIbbeta3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem 1996; 271: 7004-11.
31. Torti M, Festetics ET, Bertoni A, Sinigaglia F, Balduini C. Agonist-induced actin polymerization is required for the irreversibility of platelet aggregation. Thromb Haemost 1996; 76: 444-9.
32. Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood 1998; 91: 2645-57.
33. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem 2000; 275: 21785-8.
34. Legrand C, Dubernard V, Nurden AT. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. Blood 1989; 73: 1226-34.
35. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary by-pass. Br J Anaesth 2001; 86: 575-8.
36. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-9.
37. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9: 168-73.